Neurocrine Biosciences' US FDA approved crinecerfont is available for children and adults to treat classic congenital ...
Neurocrine Biosciences, Inc, a leading neuroscience-focused, biopharmaceutical company with a simple purpose to relieve suffering for people with great needs and but few options, has announced CRENESSITY (crinecerfont) is now commercially available in the …